Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Pratesi

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Molecules (Basel, Switzerland)|November 25, 2020
On the Different Mode of Action of Au(I)/Ag(I)-NHC Bis-Anthracenyl Complexes Towards Selected Target BiomoleculesFrancesca Binacchi, Federica Guarra, Damiano Cirri, et al.
Pharmaceutics|August 28, 2021
Anticancer Diiron Vinyliminium Complexes: A Structure-Activity Relationship StudySimona Braccini, Giorgia Rizzi, Lorenzo Biancalana, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 31, 2025
Ligand-Dependent DNA Binding and Cytotoxicity of Palladium(II) ComplexesFrancesca Binacchi, Damiano Cirri, Tania Gamberi, et al.
Journal of Inorganic Biochemistry|February 15, 2014
Insights on the mechanism of thioredoxin reductase inhibition by gold N-heterocyclic carbene compounds using the synthetic linear selenocysteine containing C-terminal peptide hTrxR(488-499): an ESI-MS investigationAlessandro Pratesi, Chiara Gabbiani, Elena Michelucci, et al.
Dalton Transactions (Cambridge, England : 2003)|August 24, 2022
Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agentDamiano Cirri, Lara Massai, Chiara Giacomelli, et al.
Dalton Transactions (Cambridge, England : 2003)|October 27, 2021
Role of the (pseudo)halido ligand in ruthenium(II) <i>p</i>-cymene α-amino acid complexes in speciation, protein reactivity and cytotoxicityLorenzo Biancalana, Emanuele Zanda, Mouna Hadiji, et al.
International Journal of Molecular Sciences|November 26, 2022
Evaluation of Auranofin Loading within Ferritin NanocagesRosanna Lucignano, Alessandro Pratesi, Paola Imbimbo, et al.
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
Protein-Based Delivery Systems for Anticancer Metallodrugs: Structure and Biological Activity of the Oxaliplatin/β-Lactoglobulin AdductDaria Maria Monti, Domenico Loreto, Ilaria Iacobucci, et al.
Dalton Transactions (Cambridge, England : 2003)|August 18, 2025
Redefining platinum(IV) chemotherapy: α-tocopherol succinate functionalization and nanoparticle encapsulation to improve cisplatin- and oxaliplatin-based therapiesCarlo Marotta, Damiano Cirri, Maria Chiara Maimone, et al.
Journal of Inorganic Biochemistry|November 16, 2021
Oxaliplatin inhibits angiogenin proliferative and cell migration effects in prostate cancer cellsTiziano Marzo, Giarita Ferraro, Lorena Maria Cucci, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Molecules (Basel, Switzerland)|November 25, 2020
On the Different Mode of Action of Au(I)/Ag(I)-NHC Bis-Anthracenyl Complexes Towards Selected Target BiomoleculesFrancesca Binacchi, Federica Guarra, Damiano Cirri, et al.
Pharmaceutics|August 28, 2021
Anticancer Diiron Vinyliminium Complexes: A Structure-Activity Relationship StudySimona Braccini, Giorgia Rizzi, Lorenzo Biancalana, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 31, 2025
Ligand-Dependent DNA Binding and Cytotoxicity of Palladium(II) ComplexesFrancesca Binacchi, Damiano Cirri, Tania Gamberi, et al.
Journal of Inorganic Biochemistry|February 15, 2014
Insights on the mechanism of thioredoxin reductase inhibition by gold N-heterocyclic carbene compounds using the synthetic linear selenocysteine containing C-terminal peptide hTrxR(488-499): an ESI-MS investigationAlessandro Pratesi, Chiara Gabbiani, Elena Michelucci, et al.
Dalton Transactions (Cambridge, England : 2003)|August 24, 2022
Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agentDamiano Cirri, Lara Massai, Chiara Giacomelli, et al.
Dalton Transactions (Cambridge, England : 2003)|October 27, 2021
Role of the (pseudo)halido ligand in ruthenium(II) <i>p</i>-cymene α-amino acid complexes in speciation, protein reactivity and cytotoxicityLorenzo Biancalana, Emanuele Zanda, Mouna Hadiji, et al.
International Journal of Molecular Sciences|November 26, 2022
Evaluation of Auranofin Loading within Ferritin NanocagesRosanna Lucignano, Alessandro Pratesi, Paola Imbimbo, et al.
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
Protein-Based Delivery Systems for Anticancer Metallodrugs: Structure and Biological Activity of the Oxaliplatin/β-Lactoglobulin AdductDaria Maria Monti, Domenico Loreto, Ilaria Iacobucci, et al.
Dalton Transactions (Cambridge, England : 2003)|August 18, 2025
Redefining platinum(IV) chemotherapy: α-tocopherol succinate functionalization and nanoparticle encapsulation to improve cisplatin- and oxaliplatin-based therapiesCarlo Marotta, Damiano Cirri, Maria Chiara Maimone, et al.
Journal of Inorganic Biochemistry|November 16, 2021
Oxaliplatin inhibits angiogenin proliferative and cell migration effects in prostate cancer cellsTiziano Marzo, Giarita Ferraro, Lorena Maria Cucci, et al.
Pageof 8